Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO)

CUSIP: 84833T103

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
55,705,828
Total 13F shares
13,876,978
Share change
+119,967
Total reported value
$18,039,320
Put/Call ratio
200%
Price per share
$1.30
Number of holders
47
Value change
+$23,111
Number of buys
17
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 84833T103?
CUSIP 84833T103 identifies SPRO - Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO) as of Q2 2024

As of 30 Jun 2024, Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,876,978 shares. The largest 10 holders included Anson Funds Management LP, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, ADAR1 Capital Management, LLC, Alphabet Inc., Murchinson Ltd., Atlas Venture Life Science Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Inc.. This page lists 47 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.